feed,title,long_url,short_url
Benzinga,GSK's Conditionally Approved Blood Cancer Drug Fails On Progression-Free Survival Goal Over Standard Care,https://benzinga.com/general/biotech/22/11/29587499/gsks-conditionally-approved-blood-cancer-drug-fails-on-progression-free-survival-goal-over-standa,https://bit.ly/3UC6CV7
Benzinga,Why Are Lidar Manufacturers Velodyne And Ouster Rallying Today,https://benzinga.com/m-a/22/11/29588192/why-are-lidar-manufacturers-velodyne-and-ouster-rallying-today,https://bit.ly/3TbwSnV
